Filing Details
- Accession Number:
- 0001104659-20-070840
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-08 16:08:59
- Reporting Period:
- 2020-06-05
- Accepted Time:
- 2020-06-08 16:08:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1279704 | Cellectar Biosciences Inc. | CLRB | Pharmaceutical Preparations (2834) | 043321804 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1326487 | Dov Elefant | C/O Cellectar Biosciences, Inc. 100 Campus Drive Florham NJ 07932 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-06-05 | 4,348 | $1.15 | 4,348 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series H Warrants | Acquisiton | 2020-06-05 | 2,174 | $0.01 | 2,174 | $1.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,174 | 2020-06-05 | 2025-06-05 | No | 4 | P | Direct |